Principal Financial Group Inc. lowered its stake in Amedisys Inc (NASDAQ:AMED) by 1.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 229,259 shares of the health services provider’s stock after selling 2,429 shares during the period. Principal Financial Group Inc. owned 0.68% of Amedisys worth $12,829,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in AMED. Federated Investors Inc. PA lifted its stake in shares of Amedisys by 2.3% in the 2nd quarter. Federated Investors Inc. PA now owns 1,929 shares of the health services provider’s stock worth $122,000 after acquiring an additional 44 shares during the period. State Board of Administration of Florida Retirement System lifted its stake in shares of Amedisys by 0.5% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 19,658 shares of the health services provider’s stock worth $1,235,000 after acquiring an additional 93 shares during the period. Municipal Employees Retirement System of Michigan lifted its stake in shares of Amedisys by 3.5% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 6,590 shares of the health services provider’s stock worth $414,000 after acquiring an additional 220 shares during the period. Suntrust Banks Inc. lifted its stake in shares of Amedisys by 4.3% in the 2nd quarter. Suntrust Banks Inc. now owns 5,702 shares of the health services provider’s stock worth $358,000 after acquiring an additional 237 shares during the period. Finally, Texas Permanent School Fund lifted its stake in Amedisys by 1.2% during the second quarter. Texas Permanent School Fund now owns 20,439 shares of the health services provider’s stock valued at $1,284,000 after purchasing an additional 243 shares during the last quarter. 94.32% of the stock is owned by institutional investors and hedge funds.
Several equities research analysts recently commented on the stock. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $62.00 price objective (up previously from $56.00) on shares of Amedisys in a research note on Thursday, November 9th. Benchmark restated a “hold” rating on shares of Amedisys in a research note on Thursday, November 9th. Craig Hallum restated a “buy” rating and set a $68.00 price target (up previously from $55.00) on shares of Amedisys in a research note on Thursday, November 9th. Robert W. Baird upped their price objective on shares of Amedisys from $50.00 to $60.00 and gave the stock a “neutral” rating in a report on Friday, November 10th. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $70.00 price objective on shares of Amedisys in a report on Friday, November 10th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Amedisys has an average rating of “Buy” and a consensus target price of $61.00.
Shares of Amedisys Inc (NASDAQ:AMED) opened at $53.85 on Friday. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16. The stock has a market cap of $1,827.51, a PE ratio of 25.77, a P/E/G ratio of 1.30 and a beta of 0.70. Amedisys Inc has a 1 year low of $39.95 and a 1 year high of $65.91.
Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Tuesday, November 7th. The health services provider reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.02. Amedisys had a net margin of 2.88% and a return on equity of 14.68%. The firm had revenue of $380.20 million during the quarter, compared to analysts’ expectations of $384.59 million. During the same quarter last year, the company posted $0.36 EPS. The company’s quarterly revenue was up 5.1% compared to the same quarter last year. analysts expect that Amedisys Inc will post 2.23 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Principal Financial Group Inc. Sells 2,429 Shares of Amedisys Inc (NASDAQ:AMED)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/12/10/principal-financial-group-inc-has-12-83-million-stake-in-amedisys-inc-amed.html.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with MarketBeat.com's FREE daily email newsletter.